Clinical Trial Update: Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating radiotherapy with anti-PD-1 therapy in low-risk extranodal NK/T-cell lymphoma, nasal type, in early-stage disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma
• Extranodal Nk-t-cell Lymphoma Nasal and Nasal-type

Drugs mentioned

• Anti-PD-1

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Early-stage, Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type | Phase 2 | Status: UNKNOWN